ArticleCancer diagnosis & prognosis

Response-survival Association Differs by Hepatic Reserve in Unresectable HCC Receiving Atezolizumab Plus Bevacizumab.

Akifumi Kuwano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.